Arunjyothi Bio Ventures Intrinsic Value

ABVL • Financial Services
Current Stock Price
₹7.52
Primary Intrinsic Value
₹13.47
Market Cap
₹14.3 Cr
+79.1% Upside
Median Value
₹13.47
Value Range
₹10 - ₹13
Assessment
Trading Below Calculated Value
Safety Margin
44.2%

ABVL Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹13.47 ₹12.12 - ₹14.82 +79.1% Book Value/Share: ₹16.84, P/B: 0.8x
Simple DCF (5Y) dcf ₹9.77 ₹7.82 - ₹11.72 +29.9% CF Growth: 5.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check ABVL share price latest .

Valuation Comparison Chart

ABVL Intrinsic Value Analysis

What is the intrinsic value of ABVL?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Arunjyothi Bio Ventures (ABVL) is ₹13.47 (median value). With the current market price of ₹7.52, this represents a +79.1% variance from our estimated fair value.

The valuation range spans from ₹9.77 to ₹13.47, indicating ₹9.77 - ₹13.47.

Is ABVL undervalued or overvalued?

Based on our multi-method analysis, Arunjyothi Bio Ventures (ABVL) appears to be trading below calculated value by approximately 79.1%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 0.68 Industry Standard: 2.0+ Below 1.5 Measures short-term liquidity capacity
Debt to Equity Ratio 1.88 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Operating Margin 38.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹2 Cr ₹-1 Cr Positive Operating Cash Flow 6/10
March 2024 ₹6 Cr ₹-6 Cr Positive Operating Cash Flow 6/10
March 2023 ₹-13 Cr ₹-23 Cr Negative Cash Flow 3/10
March 2022 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10